CN101244015A - Beauty treatment preparation containing ethenyl pyrrolidone/acrylic acid copolymer - Google Patents
Beauty treatment preparation containing ethenyl pyrrolidone/acrylic acid copolymer Download PDFInfo
- Publication number
- CN101244015A CN101244015A CNA2007101527303A CN200710152730A CN101244015A CN 101244015 A CN101244015 A CN 101244015A CN A2007101527303 A CNA2007101527303 A CN A2007101527303A CN 200710152730 A CN200710152730 A CN 200710152730A CN 101244015 A CN101244015 A CN 101244015A
- Authority
- CN
- China
- Prior art keywords
- acid
- weight
- ester
- preparation
- right amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 50
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 229920002126 Acrylic acid copolymer Polymers 0.000 title claims description 8
- 230000003796 beauty Effects 0.000 title description 9
- -1 2- benzimidazoyl Chemical group 0.000 claims abstract description 48
- 239000002537 cosmetic Substances 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 229920001577 copolymer Polymers 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims abstract description 8
- 159000000000 sodium salts Chemical class 0.000 claims abstract description 8
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 44
- 238000009472 formulation Methods 0.000 claims description 30
- 150000002148 esters Chemical class 0.000 claims description 18
- 239000000839 emulsion Substances 0.000 claims description 16
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 7
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 claims description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- FYRWKWGEFZTOQI-UHFFFAOYSA-N 3-prop-2-enoxy-2,2-bis(prop-2-enoxymethyl)propan-1-ol Chemical compound C=CCOCC(CO)(COCC=C)COCC=C FYRWKWGEFZTOQI-UHFFFAOYSA-N 0.000 claims description 4
- 229940025250 camphora Drugs 0.000 claims description 4
- 239000010238 camphora Substances 0.000 claims description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 claims description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 2
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 claims description 2
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 claims description 2
- 239000004808 2-ethylhexylester Substances 0.000 claims description 2
- VTQVLCXOOIFPBB-UHFFFAOYSA-N 4-ethyl-5-hexyl-1H-triazin-6-one Chemical compound C(C)C1=C(C(NN=N1)=O)CCCCCC VTQVLCXOOIFPBB-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- MYPBLQAHYZVHCC-UHFFFAOYSA-N C(C)N(C1=CC(=C(C(=O)C(CC2=C(C(=O)O)C=CC=C2)CCCC)C=C1)O)CC Chemical compound C(C)N(C1=CC(=C(C(=O)C(CC2=C(C(=O)O)C=CC=C2)CCCC)C=C1)O)CC MYPBLQAHYZVHCC-UHFFFAOYSA-N 0.000 claims description 2
- COPZLZQKXUPBFU-UHFFFAOYSA-N C=C(C(=O)O)C(=O)O.COC1=CC=CC=C1 Chemical compound C=C(C(=O)O)C(=O)O.COC1=CC=CC=C1 COPZLZQKXUPBFU-UHFFFAOYSA-N 0.000 claims description 2
- KJOLGFYYFSCQLR-UHFFFAOYSA-N N1=NNC(C=C1)=O.C(C)C(C(C(=O)N)CCCCCC)(C)CC Chemical compound N1=NNC(C=C1)=O.C(C)C(C(C(=O)N)CCCCCC)(C)CC KJOLGFYYFSCQLR-UHFFFAOYSA-N 0.000 claims description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims description 2
- UBNYRXMKIIGMKK-UHFFFAOYSA-N amiloxate Chemical compound COC1=CC=C(C=CC(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 claims description 2
- 229960004665 menthyl salicylate Drugs 0.000 claims description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 claims description 2
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N ortho-diethylbenzene Natural products CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 claims description 2
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 claims description 2
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 claims description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims 1
- 229940077388 benzenesulfonate Drugs 0.000 claims 1
- 150000002191 fatty alcohols Chemical class 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 abstract 2
- 230000004888 barrier function Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000003963 antioxidant agent Substances 0.000 description 11
- 235000006708 antioxidants Nutrition 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- OSORMYZMWHVFOZ-UHFFFAOYSA-N phenethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCC1=CC=CC=C1 OSORMYZMWHVFOZ-UHFFFAOYSA-N 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 241001597008 Nomeidae Species 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 7
- 229940083037 simethicone Drugs 0.000 description 7
- 229940032147 starch Drugs 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 6
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 6
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 229920002379 silicone rubber Polymers 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- BYQPMKXSZDJZAW-UHFFFAOYSA-N 1-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OC(CCC)OC(=O)CCCCCCC BYQPMKXSZDJZAW-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 229960004365 benzoic acid Drugs 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- OHCBNHXSUYKHAE-UHFFFAOYSA-N 5-ethyl-4-hexyltriazine Chemical compound CCCCCCC1=NN=NC=C1CC OHCBNHXSUYKHAE-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960000655 ensulizole Drugs 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-N hexane carboxylic acid Natural products CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229940078812 myristyl myristate Drugs 0.000 description 3
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229940098888 phenethyl benzoate Drugs 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229940074404 sodium succinate Drugs 0.000 description 3
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- ILPBINAXDRFYPL-UHFFFAOYSA-N 2-octene Chemical compound CCCCCC=CC ILPBINAXDRFYPL-UHFFFAOYSA-N 0.000 description 2
- ZDHRAACDPXUCHC-UHFFFAOYSA-N 3,4-diethyl-2-hexoxyphenol;5-methoxy-4-phenyltriazine Chemical compound COC1=CN=NN=C1C1=CC=CC=C1.CCCCCCOC1=C(O)C=CC(CC)=C1CC ZDHRAACDPXUCHC-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 206010009866 Cold sweat Diseases 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 241001460678 Napo <wasp> Species 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229920006243 acrylic copolymer Polymers 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229940111759 benzophenone-2 Drugs 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007957 coemulsifier Substances 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 229940049657 cyclomethicone 5 Drugs 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N octyldodecane Natural products CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- QQOWHRYOXYEMTL-UHFFFAOYSA-N triazin-4-amine Chemical compound N=C1C=CN=NN1 QQOWHRYOXYEMTL-UHFFFAOYSA-N 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FTSXCFQXTFOYQH-BDQAORGHSA-N (2s)-2-(octadecanoylamino)pentanedioic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O FTSXCFQXTFOYQH-BDQAORGHSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- YCTDZYMMFQCTEO-FNORWQNLSA-N (E)-3-octene Chemical compound CCCC\C=C\CC YCTDZYMMFQCTEO-FNORWQNLSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- FCGXLCNBWYIEAA-UHFFFAOYSA-N 1,3-benzothiazol-6-ylmethanamine Chemical compound NCC1=CC=C2N=CSC2=C1 FCGXLCNBWYIEAA-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical class CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- LRPFVGWWAKSVOY-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O LRPFVGWWAKSVOY-UHFFFAOYSA-N 0.000 description 1
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- FGGSPCRNKDZEKY-UHFFFAOYSA-N 3-hexoxypentane-1,2,3-triol Chemical compound CCCCCCOC(O)(CC)C(O)CO FGGSPCRNKDZEKY-UHFFFAOYSA-N 0.000 description 1
- DQHHKFVACXSZHQ-UHFFFAOYSA-N 4-(2,3-dihydroxypropoxy)-4-oxobutanoic acid Chemical class OCC(O)COC(=O)CCC(O)=O DQHHKFVACXSZHQ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- GQUAIKWWRYLALG-UHFFFAOYSA-N 4-formamido-n-[5-[[5-[3-[(9-methoxy-5,11-dimethyl-6h-pyrido[4,3-b]carbazol-1-yl)amino]propylcarbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide Chemical compound C=12C(C)=C3C4=CC(OC)=CC=C4NC3=C(C)C2=CC=NC=1NCCCNC(=O)C(N(C=1)C)=CC=1NC(=O)C(N(C=1)C)=CC=1NC(=O)C1=CC(NC=O)=CN1C GQUAIKWWRYLALG-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- DEDSYWXWMSNICT-YSMBQZINSA-N C(CCCCCCC\C=C/CCCC)(=O)O.C(C1=CC=CC=C1)OCC1=CC=CC=C1 Chemical compound C(CCCCCCC\C=C/CCCC)(=O)O.C(C1=CC=CC=C1)OCC1=CC=CC=C1 DEDSYWXWMSNICT-YSMBQZINSA-N 0.000 description 1
- FQHODMBKDHIWRL-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC([Na])=O Chemical compound CCCCCCCCCCCCCCCCCC([Na])=O FQHODMBKDHIWRL-UHFFFAOYSA-N 0.000 description 1
- SNKWTKAAHFFTIF-UHFFFAOYSA-N CCOC(C(C)OC(=O)N1CCCCC1)C Chemical compound CCOC(C(C)OC(=O)N1CCCCC1)C SNKWTKAAHFFTIF-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 description 1
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000222065 Lycoperdon Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- UTUOXQGMYXGRCI-UHFFFAOYSA-N N(=O)OC(C)CCCCCC.C(CCCCCCCCCCC)(=O)O Chemical compound N(=O)OC(C)CCCCCC.C(CCCCCCCCCCC)(=O)O UTUOXQGMYXGRCI-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- SBLKVIQSIHEQOF-UPHRSURJSA-N Octadec-9-ene-1,18-dioic-acid Chemical compound OC(=O)CCCCCCC\C=C/CCCCCCCC(O)=O SBLKVIQSIHEQOF-UPHRSURJSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000768494 Polymorphum Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000173166 Pyrus ussuriensis Species 0.000 description 1
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- UFVWHIGSVGIZRQ-UHFFFAOYSA-N bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate Chemical compound C1=C(C(=O)OCC(CC)CCCC)C=CC2=CC(C(=O)OCC(CC)CCCC)=CC=C21 UFVWHIGSVGIZRQ-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- XSIFPSYPOVKYCO-UHFFFAOYSA-N butyl benzoate Chemical group CCCCOC(=O)C1=CC=CC=C1 XSIFPSYPOVKYCO-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- 229940095081 c13-16 isoparaffin Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 229960001673 diethyltoluamide Drugs 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- DTTVNCZEOYSFFF-UHFFFAOYSA-N ethoxyurea Chemical compound CCONC(N)=O DTTVNCZEOYSFFF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960005082 etohexadiol Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- YQNXSNGULXTRIW-UHFFFAOYSA-N hexan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)CCCC YQNXSNGULXTRIW-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229940078546 isoeicosane Drugs 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Chemical compound CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940059939 kayexalate Drugs 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N methyl phenyl ether Natural products COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- WQDGUYZIAJKLAB-UHFFFAOYSA-N octan-2-yl nitrite Chemical compound CCCCCCC(C)ON=O WQDGUYZIAJKLAB-UHFFFAOYSA-N 0.000 description 1
- RDUQEQWTZYCTJZ-UHFFFAOYSA-N octyl 16-methylheptadecanoate Chemical compound CCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C RDUQEQWTZYCTJZ-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000010458 rotten stone Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- PANBYUAFMMOFOV-UHFFFAOYSA-N sodium;sulfuric acid Chemical compound [Na].OS(O)(=O)=O PANBYUAFMMOFOV-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 238000005491 wire drawing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses a cosmetic preparation, which comprises a). One or a plurality of water soluble UV barrier filtering agents selected from compound 2-phenylbenzimidazole-5-sulfonic acid and the sodium salt, the potassium salt, the triethanolamine salt and phenylene-1,4-dual- (2- benzimidazoyl) -3,3',5,5'-tetrasulfonic acid and the sodium salt, the potassium salt and the triethanolamine salt; b). Copolymer for vinyl pyrrolidone and acrylic.
Description
The present invention relates to contain the sunscreen of vinyl pyrrolidone/acrylic copolymer.
For many years, abandon enervated pale and be tending towards " the brown skin of fitness campaign " this trend and do not interrupt.In order to obtain this effect, people are exposed under the sunlight their skin, because like this can be owing to forming the generation that melanin causes color.But the ultraviolet radiation of sunlight also can produce detrimental effect to skin.Except acute damage (sun burns), accepting excessive UAB zone UV light (wavelength: will produce long-term damage, for example higher risk that causes skin carcinoma during 280-320nm) irradiation.In addition, (wavelength: excessive effect 320-400nm) can cause the elasticity of connective tissue and collagen fiber to be weakened for UVB-and UVA-ray.This will cause a large amount of phototoxicities and photoallergic reaction and cause skin aging in advance.
Therefore, will develop a series of shading mediums that can be used in the cosmetic formulation for protecting skin.This UVA-and UVB-filtering agent are all listed in most of industrial countries in the manifest of permitting import, for example the adnexa 7 of cosmetics regulation.
But many commercially available sunscreen all can't be avoided, and this preparation of prior art all has a series of defectives.
Contain and be selected from chemical compound group 2-Phenylbenzimidazole-5-sulfonic acid and sodium salt, potassium salt and tri ethanol ammonium salt or phenylene-1,4-two-(2-benzimidazolyl)-3,3 ', 5,5 '-the water solublity UV-shading filtering agent of tetrasulfonic acid and sodium salt, potassium salt and tri ethanol ammonium salt and have the very preparation of polyelectrolyte content therefrom, be difficult to be mixed with emulsion form.This emulsion according to prior art also just by in conjunction with multiple thickening agent or by using and the emulsifier system of especial manufacture and stably making reluctantly at each prescription.So the preparation that so makes has the character of non-beauty treatment usually.These emulsions have the outward appearance of Lycoperdon polymorphum Vitt character.When from storage container, taking out, can form filament and on skin, can feel to be clamminess and uncomfortable.
Therefore task of the present invention is to overcome the defective of prior art.In addition, task also is to develop the stable beauty treatment emulsion (or dispersion liquid) that has high level water solublity UV shading filtering agent based on electrolytical, and it can have good sensation on being used for skin the time.
Be surprised to find, this task solves by the cosmetic formulation that contains following component: a) one or more are selected from chemical compound 2-Phenylbenzimidazole-5-sulfonic acid and sodium salt, potassium salt and tri ethanol ammonium salt and phenylene-1,4-two-(2-benzimidazolyl)-3,3 ', 5,5 '-the water solublity UV shading filtering agent of tetrasulfonic acid and sodium salt, potassium salt and tri ethanol ammonium salt, b) vinyl pyrrolidone and acrylic acid copolymer.
Preparation of the present invention can stably be prepared with the emulsifying agent and/or the coemulsifier (for example aliphatic alcohol) of less amount astoundingly.Partly, preparation (emulsion/dispersion liquid) even can abandon coemulsifier (aliphatic alcohol) and stably make.
According to the present invention advantageously, it is the water solublity UV shading filtering agent of 0.1 to 20 weight % that preparation of the present invention is contained in total formulation weight concentration, and according to the present invention preparation of the present invention to be contained in total formulation weight amount concentration be the water solublity UV shading filtering agent of 0.1 to 10 weight %.
According to the present invention advantageously, preparation of the present invention being contained is that 0.1 to 10 weight % and preferred concentration are vinyl pyrrolidone and the acrylic acid copolymer of 0.1 to 5 weight % in total formulation weight concentration respectively.
Preferred implementation of the present invention is characterised in that water solublity UV shading filtering agent is 1: 15 to 15: 1 to the weight ratio of copolymer.
In category of the present invention, advantageously, make crosslinking copolymers of the present invention with pentaerythritol triallyl ether.In this embodiment, the present invention preferably makes polymer contain the vinyl pyrrolidone of 25-80 weight %, the acrylic acid of 20-80 weight % and the pentaerythritol triallyl ether of 0.4-2 weight %.
Preferred implementation of the present invention is characterized in that preparation exists with emulsion form, preferably the form of O/W-emulsion.
According to the present invention, the concentration of emulsifier system is preferably 0.01-6 weight % in preparation, in the gross weight of preparation.
According to the present invention, preferred preparation of the present invention also contain one or more other be selected from the UV-filtering agent of following chemical compound group: 1,4-two (the 2-oxo-bornenyl methyl of 10-sulfo--3-)-benzene and salt thereof; 2,2 '-methylene-two-(6-(2H-benzotriazole-2-yl)-4-(1,1,3, the 3-tetramethyl butyl)-phenol); 2-(2H-benzotriazole-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethyl silyl) the oxygen base] the disiloxane base] propyl group]-phenol; 3-(4-methylbenzene methylene) Camphora; 3-benzylidene Camphora; Ethylhexyl salicylate; The Terephthalidene Dicamphor Sulfonic Acid; 4-(dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(dimethylamino) benzoic acid-pentyl ester; 4-methoxybenzene methylene malonic acid two (2-ethylhexyl) ester; 4-methoxy cinnamic acid (2-ethylhexyl) ester; 4-methoxy cinnamic acid isopentyl ester; 2-hydroxyl 4-methoxy benzophenone; 2-hydroxyl-4-methoxyl group-4 '-the methyldiphenyl ketone; 2,2 '-dihydroxy-4-methoxy benzophenone; 2-(4 '-diethylamino-2 '-hydroxy benzoyl)-hexyl-benzoate; 4-(tert-butyl group)-4 '-methoxy dibenzoyl methane; High menthyl salicylate; 2-ethylhexyl-2 hydroxybenzoic acid ester; 2-ethylhexyl-2-cyano group-3,3-diphenylacrylate ester; Dimethyl polysiloxane diethylbenzene methylene malonate (Dimethicodiethylbenzalmalonat); 3-(4-(2,2-di ethoxy carbonyl vinyl)-phenoxy group) acrylic)-methoxyl group siloxanes/dimethyl siloxane-copolymer; 2,4-two-{ [4-(2-ethyl-hexyloxy)-2-hydroxyl]-phenyl }-6-(4-methoxyphenyl)-1,3,5-triazines (INCI: two-ethyl hexyl oxy phenol methoxyphenyl triazine); Dioctyl butyl amide triazinone (INCI: diethylhexyl-butyramide triazinone); 2,4-two-[5-1-(dimethyl propyl) benzoxazol-2-base-(4-phenyl)-imino group]-6-(2-ethylhexyl)-imino group-1,3,5-triazines (CAS 288254-16-0); 4,4 ', 4 " (1,3; 5-triazine-2,4,6-three basic three imino groups)-three-benzoic acid-three (2-ethyl hexyl ester) (all right: 2,4; 6-three-[anilino--(right-carbonyl-2 '-ethyl-1 '-hexyloxy]-1,3,5-triazines (INCI: the ethylhexyl triazinone)); 2,4,6-terphenyl-4-base-1,3,5-triazines; Merocyanine; Titanium dioxide; Zinc oxide.Its concentration counts 0.01 to 40 weight % with total formulation weight and preferred concentration is 1 to 30 weight %.
According to the present invention, pigment (titanium dioxide, zinc oxide) can be advantageously surface treated (" through applying "), for example should form or keep hydrophilic, both sexes or hydrophobic characteristic at this.This surface treatment process can be, according to known method with pigment with the hydrophilic of dilution and/hydrophobic inorganic and/or organic coating applies.In category of the present invention, various face coats also can contain water.
The inorganic surfaces coating can be by aluminium oxide (Al in category of the present invention
2O
3), aluminium hydroxide Al (OH)
3Or hydrated alumina (is also referred to as: vanadine, CAS number: 1333-84-2), sodium hexameta phosphate (NaPO
3)
6, Polymeric sodium metaphosphate. (NaPO
3)
n, silicon dioxide (SiO
2) (be also referred to as tripoli, CAS number: 7631-86-9), barium sulfate (BaSO
4) or ferrum oxide (Fe
2O
3) form.This inorganic surfaces coating can be separately, combination and/or exist in combination with organic-containing materials.
Organic face coat can be by the aluminium stearate of plant or animal in category of the present invention, the stearic acid of plant or animal, lauric acid, dimethyl polysiloxane (being also referred to as Dimethicone), methyl polysiloxane (Methicone), Simethicone (a kind of is the dimethyl polysiloxane of 200 to 350 dimethyl siloxane units and the mixture that silica gel constitutes by average chain length) or alginic acid.This organic face coat can be separately, combination and/or exist in combination with inorganic materials.
According to the present invention advantageously, preparation of the present invention does not contain UVINUL MBC95.
Preferred implementation of the present invention is characterized in that, it is other water soluble salts of 0.001 to 10 weight % that preparation contains in total formulation weight concentration.
So-called " water soluble salt " is interpreted as the salt of the present invention at the salt that dissolves 1g under 20 ℃ in 100g water at least.
The water of preparation of the present invention can advantageously contain conventional beauty aids, the alcohol of those of particularly low C-number for example, preferred alcohol and/or isopropyl alcohol, glycol or the polyhydric alcohol and their ether of low C number, preferably butanediol, ethohexadiol, hexanediol, pentanediol, propylene glycol, 2-methyl-prop-1,3-glycol, glycerol, ethylene glycol, ethylene glycol monoethyl ether or-monobutyl ether, propylene glycol monomethyl ether ,-single ether or-monobutyl ether, diethylene glycol monomethyl ether or-single ether and similar products, polymer, foam stabiliser.
Preparation of the present invention advantageously contains one or more film former.In category of the present invention, film former is various compositions and material that have following performance characteristic: if in film former is water-soluble or the solvent that other are suitable and then solution is coated on the skin, then it will form the film that one deck has safeguard function in fact after solvent evaporates.
Useful especially is makes film former be selected from polymer based on polyvinyl pyrrolidone (PVP).
Particularly preferably be the copolymer of polyvinyl pyrrolidone, for example PVP-hexadecene copolymer and PVP-eicosylene copolymer, they can trade name Antaron V216 and Antaron V220 buy from GAFChemicals Cooperation company.
Other aggregate into membrane also advantageously, the kayexalate of buying from NationalStarch and Chemical Corp. company with trade name Flexan 130 for example, and/or the polyisobutylene of buying with trade name Rewopal PIB 1000 from Rewo company.Other suitable polymers are such as polyacrylamide (Seppigel 305), polyvinyl alcohol, PVP, PVP/VA copolymer, Polyethylene Glycol.Use castor oil hydrogenated dimerization dilinoleic acid ester (CAS 646054-62-8 also advantageously, INCI HydrogenatedCastor Oil Dimer Dilinoleate), it can be buied from Kokyu AlcoholKogyo company by trade name Risocast DA-H, perhaps also has PPG-3 benzyl ether myristinate (CAS 403517-45-3), it can be buied from Croda Chemicals company by trade name Crodamol STS, and the Dermacryl 79 of NationalStarch company (acrylate/octyl acrylamide copolymer).
The oil phase of preparation of the present invention advantageously is selected from polar oil, for example be selected from lecithin class and fatty acid triglyceride, promptly full and/or unsaturated side chain and/or unbranched and chain length are 8 to 24, the triglyceride of the alkyl carboxylic acid of preferred especially 12 to 18 C atoms.Fatty acid triglyceride can for example advantageously be selected from synthetic, semi-synthetic and natural oil, for example Cortex cocois radicis triglyceride, olive oil, sunflower oil, soybean oil, Oleum Arachidis hypogaeae semen, Oleum Brassicae campestris, almond oil, Petiolus Trachycarpi oil, Oleum Cocois, Oleum Ricini, wheat germ oil, grape-pip oil, Ji oil (Distel l), Folium Salicis Babylonicae vegetable oil, macadimia nut oil and similar or the like.
In addition, the advantageously for example natural wax in animal and plant source, for example Cera Flava and other insect waxes and berry wax, Adeps Bovis seu Bubali resin and/or lanoline (Wollwachs) according to the present invention.
In category of the present invention, it is that the alkyl carboxylic acid of 3 to 30 C atoms and saturated and/or unsaturated side chain and/or unbranched and chain length are the ester that the alcohol of 3 to 30 C atoms forms that other favourable polar oil compositions can also be selected from by saturated and/or unsaturated side chain and/or unbranched and chain length, and to be selected from by aromatic carboxylic acid and saturated and/or unsaturated side chain and/or unbranched and chain length be the ester that the alcohol of 3 to 30 C atoms forms.Therefore, these ester oils can advantageously be selected from phenylethyl benzoate, octyl palmitate, the coconut oil monooctyl ester, the isostearic acid monooctyl ester, myristic acid octyl group dodecyl ester, octyldodecanol, the different pelargonate of 16/octadecyl, isopropyl myristate, isopropyl palmitate, isopropyl stearate, acid isopropyl, n-butyl stearate, the just own ester of lauric acid, oleic acid ester in the positive last of the ten Heavenly stems, the different monooctyl ester of stearic acid, stearic acid ester in the different ninth of the ten Heavenly Stems, isononyl isononanoate, Palmic acid 2-Octyl Nitrite, lauric acid 2-Octyl Nitrite, stearic acid 2-hexyl ester in the last of the ten Heavenly stems, Palmic acid 2-octyl group dodecyl ester, the enanthic acid stearyl, oleic acid oleic alcohol ester, the erucic acid oil alcohol ester, oleic acid two dodecenyl succinic esters, erucic acid two dodecenyl succinic esters, stearic acid three decyl ester, trimellitic acid three decyl ester and synthetic, the mixture of these semi-synthetic and natural esters is as Jojoba oil.
In addition, oil phase can advantageously be selected from dialkyl ether and dialkyl carbonate, advantageously such as two decoyl ethers (Cetiol OE) and/or two decoyl carbonic esters, for example can buy with trade name Cetiol CC from Cognis company.
In addition, also the preferred oil composition is selected from Isoeicosane, enanthic acid DOPCP, two sad/didecyl acid propylene glycol esters, caprylic/capric/two glyceryl succinates, dioctyl/didecyl butanediol ester, lactic acid C
12-13-Arrcostab, tartaric acid two C
12-13-Arrcostab, myristyl myristate, neopentanoic acid isodecyl ester, three isostearic acids, six sad/six capric acid dipentaerythritol ester, single isostearic acid propylene glycol ester, tricaprylin, Isosorbide dimethyl ether.The oil phase that particularly advantageously is preparation of the present invention contains a certain amount of benzoic acid C
12-15-Arrcostab or form by it fully.
In addition, favourable oil component is a salicylic acid butyl octyl ester (as buying with trade name Hallbrite BHB from CP Hall company) for example, benzoic acid six decyl ester and benzoic acid butyl octyl ester and their mixture (HallstarAB) and/or naphthalene diacid diethylhexyl ester (the Hallbrite TQ of Symrise company or Corapan TQ).
In the category of the present invention, also can use any mixture of this oil component and wax composition.
In addition, oil phase equally also advantageously contains nonpolar oil, for example be selected from those of side chain and unbranched hydrocarbon and wax, especially preferably mineral oil, vaseline (vaseline), paraffin oil, squalane and Squalene, polyolefin, Parleam, C13-16 isoparaffin, cyclomethicone, simethicone, phenyl front three silicone oil and 2-Methylpentadecane.In polyolefin, poly decene is preferred material.
Preparation of the present invention also can advantageously contain the material that one or more are selected from following silicone elastomer, has improved the resistance to water and/or the shading factor of product since for example using:
(a) silicone elastomer, it contains unit R
2SiO and RSiO
1.5And/or R
3SiO
0.5And/or SiO
2, wherein each radicals R is represented hydrogen, C independently of each other respectively
1-24-alkyl (for example methyl, ethyl, propyl group) or aryl (for example phenyl or tolyl), alkenyl (for example vinyl) and unit R
2SiO is to RSiO
1.5Weight ratio in 1: 1 to 30: 1 scope, select;
(b) insoluble and silicone elastomer in silicone oil with swelling ability, it obtains by organopolysiloxane (1) that contains the hydrogen that connects silicon and the additive reaction that contains the organopolysiloxane (2) of unsaturated aliphatic group, wherein select used consumption part, make the amount of unsaturated aliphatic group of the hydrogen of organopolysiloxane (1) or organopolysiloxane (2)
In 1 to 20mol% scope, when organic polysiloxanes non-annularity and
In 1 to 50mol% scope, when organic polysiloxanes is ring-type.
Advantageously silicone elastomer exists with spherical powder or gel form in category of the present invention.
The silicone elastomer that advantageously exists with the spherical powder form according to the present invention is the material with INCI title simethicone/vinyl-dimethyl silicone oil cross linked polymer, for example can buy with trade name DOW CORNING 9506 Powder from DOW CORNING company.
Special preferred silane elastomer and those are selected from the oil of hydrocarbon, artificial oil, synthetic ester, synthetic ether or their mixture of animal and/or plant origin and also use.
On the one hand, preparation is existed with the form of O/W emulsion.In this case, especially preferably make preparation contain the O/W-emulsifying agent that one or more are selected from following chemical compound group according to the present invention: stearic acid citric acid glyceride, tristerin (self emulsifying), stearic acid, stearate, polyglyceryl-3-methyl glucose distearate, Ceteareth-20, PEG-40 stearate, PEG-100 stearate, stearoyl-glutamic acid sodium and cetyl aromatic sulfuric acid sodium.
On the other hand, according to the present invention advantageously, preparation is existed with the form of W/O emulsion.In this case, especially preferably make preparation contain the W/O-emulsifying agent that one or more are selected from following chemical compound group: polyglyceryl-2-two multi-hydroxy stearic acid esters, PEG-30 two multi-hydroxy stearic acid esters, cetyl simethicone copolyol, polyglyceryl-3-diisopstearate according to the present invention.
Preparation of the present invention can also advantageously contain and has brown material of one's own, and for example dihydroxy acetone and/or melanin derivant and its are 1 weight % to 10 weight % in total formulation weight amount concentration.
In addition, preparation of the present invention can also advantageously contain the protective agent in order to protection mosquito, louse and Aranea and analog.Advantageously such as N; N-diethyl-3-methyl benzamide (trade name: Meta-delphene; " DEET "), dimethyl phthalic acid ester (trade name: Palatinol M; DMP), 1-piperidine carboxylic acid-2-(2-ethoxy)-1-methyl-propyl ester and particularly preferred 3-(N-normal-butyl-N-acetyl group-amino)-ethyl propionate (trade name Insekt Repellent 3535, Merck company buys).Protective agent both can use separately also and can be used in combination.
What can be called wetting agent (humidizer) is that those can give material or the mixture of substances of cosmetic formulation with following character, and promptly they can reduce cuticular aqueous vapor release property (being also referred to as transdermal fluid loss characteristics (TEWL)) and/or the horny layer hydration is played positive impact after applying or being scattered on the skin surface.
Wetting agent (humidizer) useful in category of the present invention is such as glycerol, and lactic acid and/or lactate be sodium lactate particularly, butanediol, propylene glycol, Biosaccaride Gum-1, Glycinesoya, the ethoxy urea, ethyl hexyl oxy glycerol, 2-pyrrolidone-5-carboxylic acid and carbamide.Particularly advantageously be to use in addition and be selected from water solublity and/or can be in water swollen and/or can utilize water and the polymerization humidizer of the polysaccharide of gelatinization.Particularly preferably be, for example, hyaluronic acid, chitosan and/or be rich in the polysaccharide of trehalose, it is compiled in chemical abstracts with registration number 178463-23-5 classification and can for example obtain from SOLABIA S.A. company with trade name Fucogel 1000.Humidizer also can be preferably used as crease-resistant active substance in order to the protecting skin pathological changes, those variations that occur during as skin aging.
In category of the present invention, advantageously make preparation of the present invention contain one or more wetting agents and its total concentration is 0.1 to 30 weight % and preferred 0.5 to 20 weight %, all in the total formulation weight amount.
Cosmetic formulation of the present invention in addition such as non-essential words can also advantageously contain the filler that those for example further improve preparation sensation and beauty treatment performance and for example can give or strengthen skin velvet or silk-like handle.In the category of the present invention, favourable filler is starch and starch derivatives (for example tapioca, PASELLI EASYGEL, ocentyl succinic aluminum-or sodium-starch and similar substance), has not both had pigment that main UV filters does not have coloration yet (for example Bornitrid etc.) and/or Aerosile
(CAS 7631-86-9) and/or Talcum.
If use antioxidant as additive or active component, then more can obtain useful especially preparation.According to the present invention, preparation advantageously contains one or more antioxidants.Can use being fit to of the cosmetic applications that is useful on or antioxidant commonly used as favourable but still antioxidant that can choose use wantonly.
Particularly preferably in using water miscible antioxidant in the category of the present invention, for example vitamin, for example ascorbic acid and derivant thereof.
Preferred anti-oxidants also has vitamin E and derivant and vitamin A and derivant thereof.
The amount of antioxidant in the preparation (one or more chemical compounds) is preferably 0.001 to 30 weight %, preferred especially 0.05 to 20 weight %, particularly 0.1 to 10 weight %, with total restatement of preparation.
If vitamin E and/or its derivant are antioxidant, then preferred its concentration separately is selected from the scope of 0.001 to 10 weight %, with total restatement of preparation.
If vitamin A or vitamin A derivative, perhaps the carotene or derivatives thereof is an antioxidant, and then preferred its concentration separately is selected from the scope of 0.001 to 10 weight %, with total restatement of preparation.
Especially preferably make cosmetic formulation contain the cosmetic activity composition, and preferred active component is an antioxidant of can protecting skin resisting Oxidation according to the present invention.
Other preferred active component are natural active matter and/or its derivant in the category of the present invention, for example α-liponic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosyl rutin, carnitine, carnosine, natural and/or synthetic isoflavone, creatine, kreatinin, taurine and/or β-alanine and 8-hexadecylene-1,16-dicarboxylic acids (binary acid, CAS 20701-68-2; INCI title in the past is an octadecene diacid) and/or licochalcone A.
Comprise all crease-resistant as is known active component such as flavone glycoside (particularly alpha-glycosyl rutin), coenzyme Q10, the prescription of the present invention of vitamin E and/or derivant and similar substance, be suitable for preventing the not dermatosis of grace attractive in appearance valuably especially, for example those that occur when skin aging are (as drying, coarse and form exsiccant wrinkle, scratch where it itches, return fat (R ü ckfettung) and reduce (after for example having a bath), visible blood vessel enlarges (Teleangiektasien, Cuperosis), cutis laxa and formation wrinkle and little microgroove, partial hyperchromatism, pigment is not enough and pigment disappearance (as senile plaque), mechanical stress resistance poor (for example being chapped from the cold) and similar symptom) and prevention skin fatigue.In addition, they also advantageously are suitable for preventing to form the apparent of drying or coarse skin.
Cosmetic formulation of the present invention can contain just like those beauty aids of usually using in these preparations, and for example antistaling agent, preservation auxiliary agent, complex form agent, antibacterial, spice, inhibition or increase foamy material, have the pigment of dyeing function and other the conventional components in pigment, thickening agent, moistening and/or the material of preserving moisture, the filler that improves dermal sensation, fat, oil, wax or beauty treatment or the dermatology preparation as alcohol, polyhydric alcohol, polymer, foam stabiliser, electrolyte, organic solvent or silicone derivative.
Preferred formulation is used for nursing skin in category of the present invention: they can play the beauty treatment anti-sunlight function, also are used as cosmetics at beauty treatment fields in addition.
Form structure according to it, cosmetic composition can for example be used as protective skin cream, day cream or late frost etc. in category of the present invention.The optional bed material that can also and preferably compositions of the present invention be used as pharmaceutical preparation.
In category of the present invention also preferred for preparation to go out its primary and foremost purpose be not protection sunlight and still contain the cosmetic formulation of a certain amount of UV-protective substance.Therefore, in day cream or cosmetics, sneak into UV-A or UV-B protective substance usually.UV-protective substance and antioxidant and randomly preserving agent also make preparation itself play effectively anti-corrupt protective effect.In addition, cosmetic formulation also can be valuably exists with the form of sunscreen.
According to the present invention, especially preferably preparation of the present invention is used for protecting skin aging (skin aging of particularly preventing UV to cause) and is used as sunscreen.
Also preferred preparation of the present invention has 5 to 8 pH value according to the present invention.This can regulate by traditional acid, alkali and buffering system and obtain.
As for use, cosmetic formulation of the present invention can with method capacity commonly used on the cosmetology be applied on skin and/or the hair.
Contrast test
A | B | C | D | E | F | ||
Trade name | Raw material | m[%] | m[%] | m[%] | m[%] | m[%] | m[%] |
Polyglyceryl-3 methyl glucose distearate | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | |
Butyl methoxydibenzoylmethise | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | |
Ethylhexyl salicylate | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | |
Phenylbenzimidazolesulfonic acid | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | ||
Glycerol | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 | |
Butanediol dicaprylate/dicaprate | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | |
Vinylpyrrolidone and acrylic acid copolymer | 1.6 | 1.6 | |||||
Pemulen TR 1 | The cross linked polymer of acrylate/acrylic acid C10-30 Arrcostab | 1.6 | |||||
Aristoflex AVC | Ammonium acryloyldime-thyltaurate// VP copolymer | 1.6 | |||||
Natrosol Plus 330CS | Cetyl hydroxyethyl cellulose | 1.6 |
Keltrol F | Xanthan gum | 1.6 | |||||
Preserving agent | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | |
Nertralizer | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | |
Spice | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | |
Water | Supply 100 | Supply 100 | Supply 100 | Supply 100 | Supply 100 | Supply 100 | |
25 ℃ of viscosity (Haake VT02) that following mPa*s represents | >10000 | 7000 | 3000 | ||||
Stability | Stable | Stable | Inhomogeneous | Stable | Inhomogeneous | Inhomogeneous | |
Outward appearance+sensation | Smooth, even, but fine dispersion, and dermal sensation is comfortable | Wire drawing is arranged | Be clamminess | Acinous clearly |
Embodiment
Following examples are used with elaboration the present invention, and are not to be to its restriction.All consumption descriptions, umber and percentage composition, if do not specify, weight that all is meant and total amount or in the gross weight of preparation.
The O/W-emulsion
Emulsion | A | B | C | D | E | F | G | H |
Glycerol stearic acid citrate | 1.5 | 1.5 | 2 | |||||
Stearic acid Pyrusussuriensis polysaccharide ester | 1.0 | |||||||
Polyglyceryl-3-methyl glucose distearate | 0.5 | 1.5 | 2.5 | 3.0 | 1.5 | |||
16/stearyl alcohol | 2 | 1.5 | ||||||
Stearyl alcohol | 2 | 1 | ||||||
Cetyl alcohol | 3 | |||||||
Vinyl pyrrolidone and acrylic acid copolymer | 0.5 | 1.5 | 1.0 | 3.0 | 1.6 | 1.5 | 0.8 | 2.0 |
The cross linked polymer of acrylate/acrylic acid C10-30 Arrcostab | 0.3 | |||||||
Benzoic acid C 12-15Arrcostab | 5 | 3 | ||||||
Butanediol dicaprylate/dicaprate | 10 | 5 | 5 | |||||
The phenethyl benzoate | 3 | |||||||
Two decoyl ethers | ||||||||
Octyl group dodecyl alcohol | 3 | 3 | 5 | |||||
Two decoyl carbonic esters | 5 | 2 |
Myristyl myristate | 1 | 2 | ||||||
The caprylic/capric triglyceride | 2 | 2 | 3 | |||||
Neopentanoic acid isodecyl ester | ||||||||
2-Methylpentadecane | 2 | |||||||
Cyclomethicone | 5 | 3 | 4 | |||||
Simethicone | 2 | |||||||
Butanediol | 2 | 5 | 8 | |||||
Glycerol | 2 | 5 | 10 | 5 | 7.5 | 4 | 2 | |
C18-38 acid triglyceride | 1 | |||||||
Diethyl hexyloxy phenol methoxyphenyl triazine | 2 | 1 | 2 | |||||
Butyl methoxydibenzoylmethise | 2.5 | 3 | 2 | 5 | ||||
Diethylamino oxybenzene formyl hexyl benzene formic acid esters | 1 | 4 | ||||||
The ethylhexyl methoxy cinnamic acid | 5 | 7.5 | ||||||
Ethylhexyl salicylate | 4 | 5 | ||||||
2-hydroxyl-4-methoxy benzophenone | 2 | |||||||
Phenylbenzimidazolesulfonic acid | 3 | 2 | 1 | 4 | 2 | 1.5 | 4 | 2 |
Phenylene-1,4-two-(2-benzimidazolyl)-3,3 ', 5,5 '-tetrasulfonic acid | 2 | 2 | ||||||
The ethylhexyl triazine | 2 | 2 | 1 | |||||
Diethylhexyl fourth amino triazine | 1 | |||||||
Octadecene diacid | 1 | |||||||
Octene succinic acid aluminum starch | 1 | |||||||
Octene sodium succinate starch | 3 | 1.5 | ||||||
Tapioca | 2 | 1 | 3 | |||||
Alcohol | 0.5 | 3 | 5 | |||||
Taurine | 0.1 | 0.2 | 0.5 | 0.2 | ||||
Folic acid | 0.01 | 0.03 | 0.01 | 0.02 | 0.03 | |||
Vitamin e acetate | 0.2 | 0.2 | 0.2 | 0.3 | 0.1 | 0.5 | ||
Na 2H 2EDTA | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.5 | ||
Perfume, preserving agent | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Pigment etc. | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Sodium hydroxide | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Water | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 |
The O/W-emulsion
Emulsion | I | K | L | M | N | O | P | Q |
The PEG-40 stearate | 1.5 | 2 | 0.8 | 0.5 | ||||
Tristerin | 3.5 | 2.6 | 2 | |||||
The stearoyl sodium hydrogen alpha-aminoglutarate | 0.05 | 0.1 | 0.2 | 0.5 | ||||
16/stearyl alcohol | 3 | |||||||
Stearyl alcohol | 2 | |||||||
Cetyl alcohol | ||||||||
The copolymer that vinyl pyrrolidone and acrylic acid form | 1.6 | 0.5 | 1.5 | 3 | 2 | 1.6 | 0.5 | 1 |
Carbomer | 0.2 | 0.3 | 0.2 | |||||
Benzoic acid C 12-15Arrcostab | 7 | 3 | 3 | 5 | 1 | 10 | ||
Butanediol dicaprylate/dicaprate | 9 | 3 | 2 | 8 | 10 | |||
The phenethyl benzoate | 5 | 2 | 5 | |||||
Two decoyl ethers | ||||||||
Octyl group dodecyl alcohol | 3 | 5 | 2 | 4 | ||||
Two decoyl carbonic esters | 2 | |||||||
Myristyl myristate | 1 | |||||||
The caprylic/capric triglyceride | 2 | |||||||
Neopentanoic acid isodecyl ester | 3 | |||||||
2-Methylpentadecane | 3 | |||||||
Cyclomethicone | 5 | 2 | ||||||
Simethicone | 5 | 2 | ||||||
Glycerol | 3 | 5 | 5 | 7 | 10 | 2 | 5 | 8 |
Diethyl hexyloxy phenol methoxyphenyl triazine | 3 | 1 | 2 | |||||
Butyl methoxydibenzoylmethise | 1 | 2.5 | 4 | 3 | ||||
Polysilicon-15 | 3 | 2 | ||||||
The ethylhexyl Methoxycinnamate | 2 | 5 | 3 | |||||
Ethylhexyl salicylate | 5 | 3 | 2 | |||||
Octocrylene | 4 | |||||||
Phenylbenzimidazolesulfonic acid | 4 | 1 | 2 | 3 | 1 | 0.5 | 1 | 2.5 |
Phenylene-1,4-two-(2-benzimidazolyl)-3,3 ', 5,5 '-tetrasulfonic acid | 2 | 1 | 3 | 0.5 | ||||
The ethylhexyl triazine | 2 | 3 | ||||||
Titanium dioxide | 0.5 | 2 | ||||||
Octene succinic acid aluminum starch | 1 | 5 | 2 | 2 | ||||
Octene sodium succinate starch | 2 | 3 | ||||||
Tapioca | 3 | 2 | ||||||
Alcohol | 2 | 5 | 4 | |||||
Folic acid | 0.03 | 0.01 | 0.03 | 0.03 | 0.02 | |||
Q10 | 0.03 | 0.05 | ||||||
Na 2H 2EDTA | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.5 |
Spice, preserving agent | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Pigment etc. | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Sodium hydroxide | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Water | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 |
The O/W-emulsion
Emulsion | S | T | U | V | W | X | Y | Z |
16/stearyl alcohol+PEG-40 Oleum Ricini+16/sodium stearyl sulfate | 2.5 | 2.5 | 3 | |||||
Tristerin SE | 1 | 1 | 1.5 | |||||
16/octodecyl alcohol polyoxyethylene (20) ether | 1 | 0.5 | 0.5 | |||||
16/stearyl alcohol | ||||||||
Stearyl alcohol | ||||||||
Cetyl alcohol | ||||||||
Acrylate/acrylic acid C10-30 alkyl ester cross-linked polymer | 0.3 | 0.5 | 0.3 | |||||
Vinyl pyrrolidone and acrylic acid copolymer | 1.5 | 1.0 | 2 | 3 | 3 | 4 | 1 | 2.5 |
Benzoic acid C 12-15Arrcostab | 10 | 5 | 4 | 3 | 2 | 5 | ||
Butanediol dicaprylate/dicaprate | 10 | 5 | 3 | 5 | 8 |
The phenethyl benzoate | 5 | 2 | ||||||
Two decoyl ethers | 2 | |||||||
Octyl group dodecyl alcohol | 2 | 2 | 1 | |||||
Two decoyl carbonic esters | 2 | 2 | ||||||
The caprylic/capric triglyceride | 3 | 3 | ||||||
Dermol 105 | 2 | 3 | ||||||
Cyclomethicone | 4 | 3 | ||||||
Simethicone | 3 | 2 | ||||||
Glycerol | 5 | 3 | 2 | 5 | 7 | 1 | 8 | 2 |
VP/ hexadecylene copolymer | 1 | 1 | ||||||
C18-38 acid triglyceride | 1 | 1 | 1 | |||||
Two-ethyl hexyl oxy phenol methoxybenzene triazine | 2 | 1 | ||||||
Butyl methoxydibenzoylmethise | 5 | 1 | 2.5 | 2.5 | 2 | |||
Homosalate | 5 | 5 | ||||||
The ethylhexyl Methoxycinnamate | 5 | 8 | 5 | 5 | ||||
Diethylamino oxybenzene formyl hexyl benzene formic acid esters | 3 | 2 | ||||||
Octocrylene | 8 | 5 | 5 | |||||
Ethylhexyl salicylate | 5 | 3 | ||||||
Phenylbenzimidazolesulfonic acid | 3 | 2 | 2 | 2 | 1 | 3 | 2 | 2 |
Phenylene-1,4-two-(2-benzimidazolyl)-3,3 ', 5,5 '-tetrasulfonic acid | 1 | 2 | 2 | 3 | 2.5 | |||
The ethylhexyl triazine | 3 | 2 | 2 | |||||
Diethylhexyl fourth amino triazine | 2 | |||||||
2-hydroxyl-4-methoxy benzophenone | 2 |
2,4-two-[5-1 (dimethyl propyl) benzoxazol-2-base-(4-phenyl)-imino group]-6-(2-ethylhexyl)-imino group-1,3,5-triazines | 3 | 1 | ||||||
Titanium dioxide | 5 | 3 | ||||||
Octene succinic acid aluminum starch | 2 | 0.5 | ||||||
Octene sodium succinate starch | 1.5 | 1 | 0.5 | |||||
Tapioca | 3 | 1 | ||||||
Alcohol | 3 | 5 | 4 | 4 | 2 | |||
Taurine | 0.5 | 0.2 | 0.6 | 1 | 0.1 | |||
Vitamin E | 1 | 0.2 | 0.5 | 0.3 | 0.5 | |||
Na 2H 2EDTA | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.5 |
Spice, preserving agent | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Pigment etc. | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Sodium hydroxide | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount | In right amount |
Water | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 | Supply 100.0 |
Claims (10)
1, cosmetic formulation comprises
A) one or more are selected from chemical compound 2-Phenylbenzimidazole-5-sulfonic acid and sodium salt, potassium salt and tri ethanol ammonium salt and phenylene-1,4-two-(2-benzimidazolyl)-3,3 ', 5,5 '-the water solublity UV shading filtering agent of tetrasulfonic acid and sodium salt, potassium salt and tri ethanol ammonium salt
B) vinyl pyrrolidone and acrylic acid copolymer.
2, cosmetic formulation as claimed in claim 1 is characterized in that, it is the water solublity UV shading filtering agent of 0.1 to 20 weight % that preparation contains in the concentration of total formulation weight amount.
3, the described cosmetic formulation of one of claim as described above is characterized in that it is vinyl pyrrolidone and the acrylic acid copolymer of 0.1 to 10 weight % that preparation contains in total formulation weight amount concentration.
4, the described cosmetic formulation of one of claim as described above is characterized in that water solublity UV shading filtering agent is 1: 15 to 15: 1 to the weight ratio of copolymer.
5, the described cosmetic formulation of one of claim as described above is characterized in that copolymer is crosslinked with pentaerythritol triallyl ether.
6, the described cosmetic formulation of one of claim as described above is characterized in that polymer contains 25-80 weight % vinyl pyrrolidone, 20-80 weight % acrylic acid and 0.4-2 weight % pentaerythritol triallyl ether.
7, the described cosmetic formulation of one of claim as described above is characterized in that preparation exists with emulsion form.
8, the described cosmetic formulation of one of claim as described above is characterized in that, preparation also contains one or more other UV-filtering agent, and it is selected from following chemical compound group: 1, and 4-two (the 2-oxo-bornenyl methyl of 10-sulfo--3-)-benzene and salt thereof; 4-(the bornenyl methyl of 2-oxo-3-) benzene sulfonate; 2-methyl-5-(the bornenyl methyl of 2-oxo-3-) sulfonate; 2,2 '-methylene-two-(6-(2H-benzotriazole-2-yl)-4-(1,1,3, the 3-tetramethyl butyl)-phenol; 2-(2H-benzotriazole-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethyl silyl) the oxygen base] the disiloxane base] propyl group]-phenol; 3-(4-methylbenzene methylene) Camphora; 3-benzylidene Camphora; Ethylhexyl salicylate; The Terephthalidene Dicamphor Sulfonic Acid; 4-(dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(dimethylamino) benzoic acid-pentyl ester; 4-methoxybenzene methylene malonic acid two (2-ethylhexyl) ester; 4-methoxy cinnamic acid (2-ethylhexyl) ester; 4-methoxy cinnamic acid isopentyl ester; 2-hydroxyl-4-methoxy benzophenone; 2-hydroxyl-4-methoxyl group-4 '-the methyldiphenyl ketone; 2,2 '-dihydroxy-4-methoxy benzophenone; 2-(4 '-diethylamino-2 '-hydroxy benzoyl)-hexyl-benzoate; 4-(tert-butyl group)-4 '-methoxy dibenzoyl methane; High menthyl salicylate; 2-ethylhexyl-2 hydroxybenzoic acid ester; 2-ethylhexyl-2-cyano group-3,3-diphenylacrylate ester; Dimethyl polysiloxane diethylbenzene methylene malonate; 3-(4-(2,2-di ethoxy carbonyl vinyl)-phenoxy group) acrylic)-methoxyl group siloxanes/dimethyl siloxane-copolymer; 2,4-two-{ [4-(2-ethyl-hexyloxy)-2-hydroxyl]-phenyl }-6-(4-methoxyphenyl)-1,3,5-triazines (INCI: two-ethyl hexyl oxy phenol methoxyphenyl triazine); Dioctyl butyl amide triazinone (INCI: diethylhexyl-butyramide triazinone); 2,4-two-[5-1-(dimethyl propyl) benzoxazol-2-base-(4-phenyl)-imino group]-6-(2-ethylhexyl)-imino group-1,3,5-triazines (CAS 288254-16-0); 4,4 ', 4 " (1,3; 5-triazine-2,4,6-three basic three imino groups)-three-benzoic acid-three (2-ethyl hexyl ester) (all right: 2,4; 6-three-[anilino--(right-carbonyl-2 '-ethyl-1 '-hexyloxy)]-1,3,5-triazines (INCI: the ethylhexyl triazinone)); 2,4,6-terphenyl-4-base-1,3,5-triazines; Merocyanine; Titanium dioxide; Zinc oxide, and concentration is counted 0.01 to 40 weight % with total formulation weight.
9, the described preparation of one of claim as described above is characterized in that, preparation also contains salt soluble in water and its concentration in total formulation weight amount 0.001 to 10 weight %.
10, the described preparation of one of claim as described above is characterized in that the not fatty alcohol of preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101527303A CN101244015B (en) | 2007-02-16 | 2007-02-16 | Cosmetic preparation containing vinylpyrrolidone/acrylic acid copolymer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101527303A CN101244015B (en) | 2007-02-16 | 2007-02-16 | Cosmetic preparation containing vinylpyrrolidone/acrylic acid copolymer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101244015A true CN101244015A (en) | 2008-08-20 |
CN101244015B CN101244015B (en) | 2012-04-18 |
Family
ID=39944842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101527303A Expired - Fee Related CN101244015B (en) | 2007-02-16 | 2007-02-16 | Cosmetic preparation containing vinylpyrrolidone/acrylic acid copolymer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101244015B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102573995A (en) * | 2009-11-05 | 2012-07-11 | 莱雅公司 | Cosmetic compositions comprising an ester derived from 4-carboxy-2-pyrrolidinone and a merocyanin screening agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10355711A1 (en) * | 2003-11-26 | 2005-06-16 | Beiersdorf Ag | Cosmetic and dermatological emulsions containing creatine and / or creatinine and electrolyte concentrations, an ionic strength of at least 50 mmol / l |
US7276230B2 (en) * | 2003-12-23 | 2007-10-02 | Avon Products, Inc. | Sunscreen compounds and compositions containing same and methods for use thereof |
-
2007
- 2007-02-16 CN CN2007101527303A patent/CN101244015B/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102573995A (en) * | 2009-11-05 | 2012-07-11 | 莱雅公司 | Cosmetic compositions comprising an ester derived from 4-carboxy-2-pyrrolidinone and a merocyanin screening agent |
Also Published As
Publication number | Publication date |
---|---|
CN101244015B (en) | 2012-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101790367B (en) | Cosmetic emulsifier composition | |
CA2834035C (en) | Clear wet sprays and gels | |
AU2008281460B2 (en) | Continuous spray sunscreen compositions | |
AU2011213623B2 (en) | Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer | |
US20100061946A1 (en) | Cosmetic formulation having glucosyl glycerides and selected perfume substances | |
US20080305056A1 (en) | Stable, low viscosity cosmetic compositions | |
US20100303910A1 (en) | Topical skin care compositions | |
ES2392790T3 (en) | Cosmetic formulation with glucosylglycerides and powdered raw materials | |
CN104936655B (en) | Include the cosmetics or dermatology emulsion of merocyanine and the emulsification system containing the amphipathic nature polyalcohol comprising at least one 2- acrylamide group methyls propane sulfonic acid unit | |
US20130336905A1 (en) | Compositions of enhanced viscosity, clarity, or both enhanced viscosity and clarity | |
BR112016000139B1 (en) | uv selection composition comprising a uv filter, an organopolysiloxane functionalized with an uv light absorption group and porous silica and / or polymethylmethacrylate particles | |
US20040120905A1 (en) | Sunscreen compositions and methods of use thereof | |
AU2007201001B2 (en) | Use of ester quats in compositions as sand-repellent substances | |
US7078022B2 (en) | Sunscreen compositions and methods of use thereof | |
ES2607033T3 (en) | Cosmetic preparation scented with citronellol | |
ES2430212T3 (en) | Tinted preparation for day care | |
US20080193395A1 (en) | Cosmetic preparation with vinylpyrrolidone/acrylic acid copolymer | |
CN101244015B (en) | Cosmetic preparation containing vinylpyrrolidone/acrylic acid copolymer | |
CN103705398A (en) | Cosmetic emulsion with polyacrylate | |
ES2562079T3 (en) | New cosmetic emulsifying combination | |
CN105120831B (en) | Sunscreen composition comprising fatty acid and non-ionic linear polymer | |
ES2332539T3 (en) | COSMETIC PREPARATION WITH HYDROSOLUBLE UV LIGHT FILTER AND A COPYLIMER OF VINYL PIRROLIDINE / ACRYLIC ACID. | |
CN114630651B (en) | Sunscreen compositions with low tack | |
CN117320687A (en) | Sun protection composition containing Bei Mo triazinyl alcohol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20190216 |
|
CF01 | Termination of patent right due to non-payment of annual fee |